|
Name: AH-7921 (3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl]benzamide))
Type: Synthetic opioid
AKA: AH-7921
![AH-7921 (3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl]benzamide)) image](https://grammasearch.com/dev/v2/img/synthopiod.png)
|
|
II. Natural Derivative
Synthetic substance, no natural derivative
 |
![AH-7921 (3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl]benzamide)) image](https://grammasearch.com/dev/v2/pages/pubchem_images/119404046.png)
|
|
IV. History
AH-7921, developed in the 1970s, is a synthetic opioid analgesic. It was investigated as a potential pain reliever but has been overshadowed by other opioids. It is known for its strong effects and potential for abuse, leading to its regulation and limited use in clinical settings.
|
|
V. Legal Information
AH-7921, a synthetic opioid, is regulated as a controlled substance in many countries due to its potential for abuse. Its status reflects efforts to manage opioid use and prevent misuse.
US Federal Schedule - I
Schedule I drugs, substances, or chemicals are defined as drugs with no currently accepted medical use and a high potential for abuse. Some examples of Schedule I drugs are: heroin, lysergic acid diethylamide (LSD), marijuana (cannabis), 3,4-methylenedioxymethamphetamine (ecstasy), methaqualone, and peyote.
Key US Federal Policies:
Controlled Substances Act. Public Law: Public Law 91-513 (text can be found on GovInfo) (https://www.dea.gov/drug-information/csa). Date enacted: October 27, 1970.
|
|
VI. Physical Effects
AH-7921 is a synthetic opioid known for its potent analgesic effects. It acts as a downer, causing significant sedation and respiratory depression. Short-term use can manage pain effectively, but long-term use may lead to addiction and tolerance. Overdose risks include severe respiratory depression and potential death. Safe use requires precise dosing and medical supervision. Recent research focuses on its potency and safety compared to other opioids.  |
|
VII. Psychological Effects
AH-7921, an opioid, impacts opioid receptors to provide analgesia and mood alteration. Immediate effects include euphoria and cognitive impairment, with long-term use carrying risks of dependence and mental health issues. Research focuses on its efficacy and abuse potential.
 |
|
VIII. Culture
AH-7921 is a synthetic opioid that emerged in the late 20th century. It has been used in research and has cultural significance due to its opioid effects and potential for misuse. Proponents discuss its effects in pain management research, while opponents highlight its addiction potential and safety concerns. Its use is primarily in research contexts, reflecting broader issues in opioid treatment.
 |